Safety of Pioglitazone for Hematoma Resolution In Intracerebral Hemorrhage (SHRINC)

This study is ongoing, but not recruiting participants.
Sponsor:
Information provided by (Responsible Party):
Nicole Gonzales, The University of Texas Health Science Center, Houston
ClinicalTrials.gov Identifier:
NCT00827892
First received: January 21, 2009
Last updated: May 16, 2013
Last verified: May 2013
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is ongoing, but not recruiting participants.
  Estimated Study Completion Date: October 2013
  Estimated Primary Completion Date: October 2013 (Final data collection date for primary outcome measure)